本文選題：董氏奇穴 + 皮內(nèi)針　； 參考：《廣州中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:通過皮內(nèi)針埋針董氏奇穴與西藥芬必得治療寒濕凝滯型原發(fā)性痛經(jīng)的對(duì)照研究,分析評(píng)價(jià)皮內(nèi)針埋針董氏奇穴療法對(duì)寒濕凝滯型原發(fā)性痛經(jīng)的有效性及安全性。方法:本課題病例來(lái)源于惠州市大亞灣區(qū)第一中學(xué)高中部校醫(yī)室就診患者,收集符合納入標(biāo)準(zhǔn)病例60例,脫落2個(gè)病例,研究結(jié)束時(shí)共收入統(tǒng)計(jì)分析的病例共58例,其中皮內(nèi)針埋針董氏奇穴組30例和西藥芬必得組28例。治療組選用董氏奇穴中婦科穴(雙穴)及還巢穴(雙穴交替使用),采用圖釘型皮內(nèi)針(華佗牌,格是中0.25X1.3mm)于痛經(jīng)發(fā)作時(shí)埋針,埋針時(shí)間為2天。對(duì)照組選用芬必得布洛芬緩釋膠囊進(jìn)行治療。藥品規(guī)格為0.3*20粒/盒。受試者每次服藥1粒,一日兩次(清晨傍晚各一次),飯后服藥。痛經(jīng)發(fā)作時(shí)服藥,服藥2天。本研究設(shè)定1個(gè)月經(jīng)周期為1個(gè)療程,均連續(xù)完成3個(gè)月經(jīng)周期的治療。研究者分別在治療前、療程1結(jié)束后、療程2結(jié)束后、療程3結(jié)束后、療程結(jié)束后隨訪1個(gè)月這個(gè)5個(gè)節(jié)點(diǎn)選用視覺模擬評(píng)分量表、痛經(jīng)癥狀評(píng)分量表作為療效觀察指標(biāo)進(jìn)行觀察記錄。同時(shí),研究中需謹(jǐn)慎觀察并記錄研究中的可能出現(xiàn)的不良反應(yīng)或副作用。研究結(jié)束后,將所有記錄數(shù)值錄入統(tǒng)計(jì)分析SPSS軟件包中,進(jìn)行數(shù)據(jù)的統(tǒng)計(jì)分析。計(jì)量資料根據(jù)方差齊性選取t檢驗(yàn)或秩和檢驗(yàn);雙側(cè)檢驗(yàn),檢驗(yàn)水平設(shè)為a=0.05。結(jié)果:治療組在治療前后VAS評(píng)分如下:治療前7.17±1.21;療程1結(jié)束后6.13±1.17;療程2結(jié)束后5.30±0.75;療程3結(jié)束后4.73±0.79;療程結(jié)束后隨訪1個(gè)月5.87±0.94;治療組治療前與各療程結(jié)束后對(duì)比,對(duì)應(yīng)的t值分別為:31.000、14.000、14.250、8.963;對(duì)應(yīng)P值均為0.000。對(duì)照組在治療前后VAS評(píng)分如下:治療前7.11±1.29;療程1結(jié)束后5.46±1.00;療程2結(jié)束后4.39±0.83;療程3結(jié)束后3.32±0.98;隨訪1個(gè)月6.57±1.73;對(duì)照組治療前與各療程結(jié)束后對(duì)比,對(duì)應(yīng)的t值分別為12.813、16.016、20.139、4.448;對(duì)應(yīng)的P值均為0.000。治療組與對(duì)照組在治療前與每療程結(jié)束后及隨訪1個(gè)月的組間對(duì)比,對(duì)應(yīng)t值分別為:0.182、2.338、4.369、6.064、-2.268;對(duì)應(yīng)P值分別為:0.856、0.023、0.000、0.000、0.028。治療組在治療前后痛經(jīng)癥狀評(píng)分如下:治療前14.10±3.43;療程1結(jié)束后11.27±3.10;療程2結(jié)束后9.40±2.46;療程3結(jié)束后8.70±2.41;療程結(jié)束后隨訪1個(gè)月10.30±3.21;治療組治療前與各療程結(jié)束后對(duì)比,對(duì)應(yīng)的t值分別為:19.607、19.547、21.060、42.982;對(duì)應(yīng)P值均為0.000。對(duì)照組在治療前后痛經(jīng)癥狀評(píng)分如下:治療前14.29±3.47;療程1結(jié)束后11.18±2.47;療程2結(jié)束后9.14±1.72;療程3結(jié)束后7.57±1.50;隨訪1個(gè)月12.29±2.67;對(duì)照組治療前與各療程結(jié)束后對(duì)比,對(duì)應(yīng)的t值分別為13.395、13.049、15.088、9.165;對(duì)應(yīng)的P值均為0.000。治療組與對(duì)照組在治療前與每療程結(jié)束后及隨訪1個(gè)月的組間對(duì)比,對(duì)應(yīng) t 值分別為:-0.205、0.119、0.465、2.156、-2.555;對(duì)應(yīng)P值分別為:。0.838、0.905、0.644、0.036、0.013。皮內(nèi)針埋針董氏奇穴療法及芬必得治療寒濕凝滯型原發(fā)性痛經(jīng)在治療前后,基于VAS評(píng)分、痛經(jīng)癥狀評(píng)分的組內(nèi)比較,有統(tǒng)計(jì)學(xué)差異(P0.05)。同時(shí),在治療結(jié)束后的VAS評(píng)分及痛經(jīng)癥狀評(píng)分對(duì)比中,對(duì)照組評(píng)分下降更多,且兩組差異有統(tǒng)計(jì)學(xué)意義(P0.05)。但是在隨訪1個(gè)月,對(duì)照組的評(píng)分回升比治療組更多,且兩組對(duì)比差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:皮內(nèi)針埋針董氏奇穴與西藥芬必得均可降低青春期原發(fā)性痛經(jīng)患者的視覺模擬評(píng)分量表(VAS)評(píng)分和痛經(jīng)癥狀評(píng)分表評(píng)分。在近期療效上西藥芬必得明顯優(yōu)于皮內(nèi)針埋針董氏奇穴。但是在隨訪停止治療后1個(gè)月時(shí),西藥芬必得組評(píng)分出現(xiàn)較大的回升,皮內(nèi)針組評(píng)分回升幅度較小,因此在本研究中皮內(nèi)針埋針董氏奇穴遠(yuǎn)期療效優(yōu)于西藥芬必得。本研究治療組和對(duì)照組在研究開展治療前后及研究治療期間都沒有出現(xiàn)不良反應(yīng)。
[Abstract]:Objective: To evaluate the efficacy and safety of Dong Shi point therapy for cold dampness and stagnation of primary dysmenorrhea by intradermal needle burial needle and Western medicine finvert in treating primary dysmenorrhea. Methods: the case was derived from the school medical room of high school in the first middle school in Dayawan District, Huizhou. A total of 58 cases were collected, including 60 cases of standard cases, 2 cases, and 58 cases of total income statistical analysis at the end of the study. Among them, 30 cases of intradermal needle burial acupuncture point group and 28 western medicine finch group were used. The treatment group was used in Dong's acupoint of gynecologic acupoints (double points) and nesting points (double acupoints alternately used), and tack type intradermal needles (Hua Tuo brand). In the case of middle 0.25X1.3mm) the needle was buried at 2 days. The control group was treated with finp Ibuprofen Sustained-Release Capsules. The size of the drug was 0.3*20 granule / box. The subjects took 1 tablets each time, two times a day (each morning in the morning), after meals, taking medicine and taking medicine for 2 days. The study set up 1 menstrual cycles for 1. After the course of treatment, 3 menstrual cycles were completed. After the treatment, the researchers were treated after the treatment of 1, after the end of the course of treatment, after the end of the course of treatment, after the end of the course of treatment, after the end of the course of treatment, after the end of the course of 3, after the end of the course was followed up for 1 months, the 5 nodes selected the visual analogue scale, the dysmenorrhea symptom scale was observed as the observation index of the curative effect. Meanwhile, the study should be cautious. Check and record the possible adverse reactions or side effects in the study. After the study, all the records were recorded in the statistical analysis SPSS software package to carry out the statistical analysis of the data. The measurement data were selected according to the homogeneity of variance t test or rank sum test; the bilateral test and the test water were set to a=0.05. results: the treatment group was evaluated before and after the treatment of VAS. The scores were as follows: 7.17 + 1.21 before the treatment, 6.13 + 1.17 after the end of the course 1, 5.30 + 0.75 after the treatment of the course of treatment, 4.73 + 0.79 after the end of the course of treatment, and 4.73 + 0.79 after the end of the course of treatment; the treatment group was compared with the end of each course after the course of treatment. The corresponding T values were respectively 31.000,14.000,14.250,8.963; the corresponding P values were all VAS before and after the treatment in the 0.000. control group. The scores were as follows: 7.11 + 1.29 before the treatment, 5.46 + 1 after the end of the course of treatment, 4.39 + 0.83 after the treatment of the course of treatment, 3.32 + 0.98 after the end of the course of the course of treatment, 1 months of 6.57 + 1 months follow-up, and the corresponding T values of the control group were 12.813,16.016,20.139,4.448 before the treatment, and the corresponding P values were both before the treatment and each treatment in the 0.000. treatment group and the control group. After 1 months of follow-up, the corresponding T values were 0.182,2.338,4.369,6.064 and -2.268, and the corresponding P values were as follows: the symptoms of dysmenorrhea before and after treatment in 0.856,0.023,0.000,0.000,0.028. treatment group were as follows: 14.10 + 3.43 before treatment, 11.27 + 3.10 after the end of the course of treatment, 9.40 + 2.46 after the end of the course 2, and 8.70 + 2.41 after the end of 3 course of treatment; After the course of treatment, follow up 1 months 10.30 + 3.21, the treatment group before treatment and after the end of the treatment, the corresponding T values are: 19.607,19.547,21.060,42.982, the corresponding P values are 0.000. control group before and after treatment of dysmenorrhea symptom score as follows: before treatment 14.29 + 3.47, 11.18 + 2.47 after the end of the course of treatment, 9.14 + 1.72 after the end of the course of treatment, 3 end of course 3 end. After 7.57 + 1.50, the follow-up was 1 months 12.29 + 2.67, the control group was compared with the end of each course after treatment, the corresponding t value was 13.395,13.049,15.088,9.165, and the corresponding P values were compared between the 0.000. treatment group and the control group before and after each course and followed up for 1 months. The corresponding T values were -0.205,0.119,0.465,2.156, -2.555, respectively. The corresponding P values were:.0.838,0.905,0.644,0.036,0.013. intradermal needle burial acupuncture point therapy and the treatment of cold dampness and stagnation of primary dysmenorrhea before and after treatment, based on VAS score, compared with the scores of dysmenorrhea, there were statistical differences (P0.05). At the same time, the comparison of the VAS score and the dysmenorrhea symptom score after the end of the treatment was compared. The score of the group decreased more, and the difference between the two groups was statistically significant (P0.05). But in the 1 months of follow-up, the score of the control group was higher than that in the treatment group, and the difference between the two groups was statistically significant (P0.05). Conclusion: the visual analogue scale of the patients with primary dysmenorrhea in puberty can be reduced by the intradermal needle burial needle and the western medicine finp (V AS) score and dysmenorrhea score. In the near future, the western medicine Finn must be significantly better than the intradermal needle Dong Shiqi point. But in the 1 months after the cessation of treatment, the score of the western medicine Finn must have a greater recovery, and the score of the intradermal acupuncture group is smaller. Therefore, the long term effect of the intradermal needles in this study is in this study. There was no adverse reaction in the treatment group and the control group before and after the treatment.

【學(xué)位授予單位】：廣州中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R246.3
，

本文編號(hào)：1843966